NIH to evaluate remdesivir treatment for COVID during pregnancy
Por um escritor misterioso
Descrição
WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]
Remdesivir in pregnant women with moderate to severe coronavirus
Therapeutic dilemmas in addressing SARS-CoV-2 infection
Summary of Guidance for Minimizing the Impact of COVID-19 on
Covid-19 Research Opens to Little-Studied Group: Pregnant Patients
Favipiravir, camostat, and ciclesonide combination therapy in
Frontiers Drugs for the prevention and treatment of COVID-19 and
The Incidence, Severity, and Management of COVID-19 in Critically
Critical study of Gilead drug shows coronavirus patients
Remdesivir Now Approved for COVID Outpatients, Too
de
por adulto (o preço varia de acordo com o tamanho do grupo)
